ArticleFrontiers in immunology2026

Broadly neutralizing single-domain antibody targeting the spike NTD displays therapeutic efficacy against diverse SARS-CoV-2 variants.

Anastasia I Korobkova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.